MHT in menopausal women at risk: comorbidity cerebrovascular disease

Because stroke incidence increases with age, the absolute risk of stroke associated with standard-dose hormone therapy will be less among women close to the time of menopause, the group of women more likely to consider hormone therapy for vasomotor symptoms. These risks, which are rare but not negligible, should be considered by mid-life women and their physicians when discussing hormone therapy initiation and maintenance for treatment of vasomotor symptoms.
Source: Maturitas - Category: Primary Care Authors: Tags: INV34 Source Type: research